Gantenbein AR, Kamm CP, Schankin CJ, Zecca C, et al. Swiss Quality of Life and Health Care Impact Assessment in a Real-World Erenumab-Treated Migraine Population: Results over 2 years. Headache 2025 Apr 30. doi: 10.1111/head.14943.
PMID: 40304557